Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)

Description

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Conditions

Neonatal Jaundice

Talk to us

Study Overview

On this page

Study Details

Study overview

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice in Newborns with High Melanin Content (Chicago)

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)

Condition
Neonatal Jaundice
Intervention / Treatment

-

Contacts and Locations

Chicago

University of Chicago, Chicago, Illinois, United States, 60637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Infants born with gestational age \> 35 weeks.
  • * Birth weight ≥ 1800 grams
  • * Age 1 - 14 days
  • * Infants requiring a TSB blood sample for clinically suspected jaundice as part of standard care
  • * Infants showing signs of inborn disease.
  • * Infants with skin rash or other skin disease that affects the skin where measurements are performed.
  • * Infants transferred to the pediatric ward for medical treatment.
  • * Infants that have received phototherapy in the last 24 hours

Ages Eligible for Study

1 Day to 14 Days

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Picterus AS,

Jeanmarie Schied, MD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

2025-06-15